Aldosterone antagonists in the treatment of hypertension and target organ damage (Q34251366)

31 July 2017

1 reference

title

Aldosterone antagonists in the treatment of hypertension and target organ damage (English)

1 reference

31 July 2017

Rajagopalan S

1

1 reference

PubMed ID

11353575

31 July 2017

Pitt B

series ordinal

2

1 reference

31 July 2017

1 June 2001

1 reference

Current Hypertension Reports

31 July 2017

1 reference

31 July 2017

3

1 reference

31 July 2017

3

1 reference

31 July 2017

240-248

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-001-0046-2

31 July 2017

0 references

cites work

Aldosterone antagonists destabilize the mineralocorticosteroid receptor

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0046-2

Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0046-2

Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0046-2

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0046-2

Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0046-2

Inhibition of adrenal cell aldosterone synthesis by endogenous nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0046-2

Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0046-2

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0046-2

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-001-0046-2

Production of aldosterone in isolated rat blood vessels

21 January 2018

1 reference

12 December 2020

Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation

1 reference

12 December 2020

Specific nongenomic actions of aldosterone

1 reference

12 December 2020

Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta

1 reference

12 December 2020

Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone

1 reference

12 December 2020

Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance

1 reference

12 December 2020

The role of nitric oxide in the regulation of aldosterone synthesis by adrenal glomerulosa cells.

1 reference

12 December 2020

Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production

1 reference

12 December 2020

Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors

1 reference

12 December 2020

The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase

1 reference

12 December 2020

Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt

1 reference

12 December 2020

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

1 reference

12 December 2020

Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist

1 reference

12 December 2020

Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA from rat hippocampus

1 reference

12 December 2020

Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy

1 reference

12 December 2020

Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland

1 reference

12 December 2020

Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: subcellular localization of calcium elevations by single cell imaging

1 reference

12 December 2020

11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess

1 reference

12 December 2020

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

1 reference

12 December 2020

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

1 reference

12 December 2020

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy

1 reference

12 December 2020

High affinity NAD(+)-dependent 11 beta-hydroxysteroid dehydrogenase in the human heart

1 reference

12 December 2020

Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension.

1 reference

12 December 2020

Vascular aldosterone in genetically hypertensive rats

1 reference

12 December 2020

Mineralocorticoid action.

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats

1 reference

12 December 2020

Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping

1 reference

12 December 2020

Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor

1 reference

12 December 2020

Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts

1 reference

12 December 2020

Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis

1 reference

12 December 2020

Chymase-dependent angiotensin II formation in human vascular tissue

1 reference

12 December 2020

Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription

1 reference

12 December 2020

The expression of steroidogenic enzyme genes in human vascular cells

1 reference

12 December 2020

Nitric oxide inhibits human aldosteronogenesis without guanylyl cyclase stimulation

1 reference

12 December 2020

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

1 reference

12 December 2020

Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor

1 reference

12 December 2020

Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation

1 reference

12 December 2020

Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.

1 reference

12 December 2020

Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension

1 reference

12 December 2020

Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells.

1 reference

12 December 2020

Vasodilation to acetylcholine in primary and secondary forms of human hypertension

1 reference

12 December 2020

Aldosterone, salt and cardiac fibrosis

1 reference

12 December 2020

11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.

1 reference

12 December 2020

10.1007/S11906-001-0046-2

Identifiers

DOI

1 reference

PubMed ID

11353575

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11353575